Advertisement
U.S. Markets open in 8 hrs 56 mins

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.9330+0.0173 (+1.89%)
At close: 04:00PM EST
0.9661 +0.03 (+3.55%)
After hours: 05:52PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
37,235
39,504
28,229
10,105
2,435
Operating Income
-37,235
-39,504
-28,229
-10,105
-2,435
Net Non Operating Interest Income Expense
521.355
498.964
182.802
-2.414
-1,348
Other Income Expense
741.283
-239.216
-194.709
1,591
-
Pretax Income
-35,972
-39,244
-28,241
-8,516
-3,783
Tax Provision
22.316
16.949
20.777
6.004
0.8
Net Income Common Stockholders
-35,995
-39,261
-28,261
-8,522
-3,783
Diluted NI Available to Com Stockholders
-35,995
-39,261
-28,261
-8,522
-3,783
Basic EPS
-1.68
-1.65
-1.25
-0.58
-1.24
Diluted EPS
-1.68
-1.65
-1.25
-0.58
-1.24
Basic Average Shares
22,545
23,798
19,516
14,791
3,062
Diluted Average Shares
22,545
23,798
19,516
14,791
3,062
Total Operating Income as Reported
-37,235
-39,504
-28,229
-10,105
-2,435
Total Expenses
37,235
39,504
28,229
10,105
2,435
Net Income from Continuing & Discontinued Operation
-35,995
-39,261
-28,261
-8,522
-3,783
Normalized Income
-36,676
-39,072
-28,108
-9,683
-3,783
Interest Income
509.581
498.964
182.802
-
105.183
Interest Expense
-
-
-
2.414
1,453
Net Interest Income
521.355
498.964
182.802
-2.414
-1,348
EBIT
-36,244
-39,504
-28,229
-8,513
-2,329
EBITDA
-36,244
-39,504
-28,229
-8,513
-2,329
Reconciled Depreciation
-
-
-
0
0.591
Net Income from Continuing Operation Net Minority Interest
-35,995
-39,261
-28,261
-8,522
-3,783
Total Unusual Items Excluding Goodwill
862.285
-239.216
-194.709
1,591
-
Total Unusual Items
862.285
-239.216
-194.709
1,591
-
Normalized EBITDA
-37,106
-39,264
-28,034
-10,105
-2,329
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
181.0799
-50.2354
-40.8889
429.5848
0